Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective, randomized, double-blind trial of bivalirudin vs unfractionated heparin in PCI
2005-003013-32Phase 4Completed
- Sponsor
- Deutsches Herzzentrum München
- Start
- Sep 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis comparing Bivalirudin arm with Unfractionated heparin arm (2 arms). Primary endpoint: Composite ischemic endpoint at 30 days. Started Sep 2005; status: completed.
02
Drugs
bivalirudinheparin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2005-003013-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003013-32.